Ying-jie Su
Shanghai, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Case Report: Immune-related eruptive keratoacanthoma with fungal coinfection under PD-1 inhibitor therapy: a diagnostic and therapeutic challenge.
Journal: Frontiers in pharmacology
Published: April 28, 2025
A network comparison on efficacy and safety profiling of PD-1/PD-L1 inhibitors in first-line treatment of advanced non-small cell lung cancer.
Journal: Frontiers in pharmacology
Published: October 24, 2024
Adherence to endocrine therapy in patients with hormone receptor-positive early-stage breast cancer: a retrospective study.
Journal: International journal of clinical pharmacy
Published: March 24, 2022
Toxicity spectrum of immunotherapy in advanced lung cancer: A safety analysis from clinical trials and a pharmacovigilance system.
Journal: EClinicalMedicine
Published: March 23, 2022
A Network Comparison on Safety Profiling of Immune Checkpoint Inhibitors in Advanced Lung Cancer.
Journal: Frontiers in immunology
Published: August 18, 2021
Drug-related problems among hospitalized cancer pain patients: an investigative single-arm intervention trial.
Journal: Annals of palliative medicine
Published: July 22, 2020
Preliminary exploration on the role of clinical pharmacists in cancer pain pharmacotherapy.
Journal: Annals of palliative medicine
Published: March 12, 2020
A fatal myelosuppression, diarrhea and neurotoxicity induced by combination of irinotecan and tegafur-gimeracil-oteracil potassium in the treatment of colon cancer: a case report.
Journal: Translational cancer research
Published: September 29, 2019
Net Clinical Benefit of Non-vitamin K Antagonist Oral Anticoagulants for Venous Thromboembolism Prophylaxis in Patients With Cancer: A Systematic Review and Trade-Off Analysis From 9 Randomized Controlled Trials.
Journal: Frontiers in pharmacology
Published: March 16, 2018
Showing 1-9 of 9
Last Updated: 09/26/2026